Cargando…

Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance

While addition of the first-approved protease inhibitors (PIs), telaprevir and boceprevir, to pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy significantly increased sustained virologic response (SVR) rates, PI-based triple therapy for the treatment of chronic hepatitis C viru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesalam, Ahmed Atef, Vercauteren, Koen, Meuleman, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926196/ https://www.ncbi.nlm.nih.gov/pubmed/27338446 http://dx.doi.org/10.3390/v8060176

Ejemplares similares

Animal Models to Study Hepatitis C Virus Infection
por: Burm, Rani, et al.
Publicado: (2018)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
por: Desombere, Isabelle, et al.
Publicado: (2017)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

Animal Models for Hepatitis E Virus
por: Corneillie, Laura, et al.
Publicado: (2019)

Hepatitis C virus infection and related liver disease: the quest for the best animal model
por: Mailly, Laurent, et al.
Publicado: (2013)

Elucidating the differences in pathogenicity between hepatitis E virus genotypes: The quest continues
por: Vercouter, Ann‐Sofie, et al.
Publicado: (2018)

Melatonin Abrogates the Anti-Developmental Effect of the AKT Inhibitor SH6 in Bovine Oocytes and Embryos
por: El Sheikh, Marwa, et al.
Publicado: (2019)

Attenuation of Oxidative Stress and Regulation of AKT Signaling by Vanillic Acid during Bovine Pre-Implantation Embryo Development
por: El-Sheikh, Marwa, et al.
Publicado: (2023)

Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry
por: Maillard, Patrick, et al.
Publicado: (2011)

Nicotinamide Supplementation during the In Vitro Maturation of Oocytes Improves the Developmental Competence of Preimplantation Embryos: Potential Link to SIRT1/AKT Signaling
por: El Sheikh, Marwa, et al.
Publicado: (2020)

Artemisinin Analogues as Potent Inhibitors of In Vitro Hepatitis C Virus Replication
por: Obeid, Susan, et al.
Publicado: (2013)

Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems
por: Burkard, Thomas, et al.
Publicado: (2022)

Hepatitis C Virus-Related Lymphomagenesis in a Mouse Model
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2011)

Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses
por: Tesfaye, Abeba, et al.
Publicado: (2013)

Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
por: El-Sheikh, Marwa, et al.
Publicado: (2023)

Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1
por: Perin, Paula M., et al.
Publicado: (2015)

Induction of Oxidative Stress and Mitochondrial Dysfunction by Juglone Affects the Development of Bovine Oocytes
por: Mesalam, Ahmed Atef, et al.
Publicado: (2020)

A genetically humanized mouse model for hepatitis C virus infection
por: Dorner, Marcus, et al.
Publicado: (2011)

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice
por: Andreo, Ursula, et al.
Publicado: (2017)

Vascular endothelial growth factor: A novel marker for torsion-induced incomplete cervical dilatation in Egyptian buffaloes
por: Ibrahim, Ahmed, et al.
Publicado: (2022)

Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model
por: Zheng, Zhiqiang, et al.
Publicado: (2017)

Clearance of persistent hepatitis C virus infection using a claudin-1-targeting monoclonal antibody
por: Mailly, Laurent, et al.
Publicado: (2015)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
por: von Schaewen, Markus, et al.
Publicado: (2016)

A Role for B Cells to Transmit Hepatitis C Virus Infection
por: Desombere, Isabelle, et al.
Publicado: (2021)

In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment
por: Eltahla, Auda A., et al.
Publicado: (2017)

Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions
por: Ridruejo, Ezequiel, et al.
Publicado: (2021)

Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System
por: Biomy, Reda, et al.
Publicado: (2017)

Melatonin Alleviates the Toxicity of High Nicotinamide Concentrations in Oocytes: Potential Interaction with Nicotinamide Methylation Signaling
por: El-Sheikh, Marwa, et al.
Publicado: (2021)

Alcohol Induced Hepatic Degeneration in a Hepatitis C Virus Core Protein Transgenic Mouse Model
por: Noh, Dong-Hyung, et al.
Publicado: (2014)

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
por: Douglas, Mark W., et al.
Publicado: (2020)

Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt
por: Shoun, Aly Atef, et al.
Publicado: (2022)

Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

Mouse models for hepatitis B virus research
por: Hwang, Jeong-Ryul, et al.
Publicado: (2018)

Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis
por: Arshad, Muhammad Imran, et al.
Publicado: (2013)

Mouse hepatitis virus
por: Haring, Jodie, et al.
Publicado: (2001)

Mouse Hepatitis Virus
por: W. Barthold, Stephen, et al.
Publicado: (2007)

Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD
por: Zhang, Hui, et al.
Publicado: (2019)

Selection of hepatitis C virus resistant to ribavirin
por: Feigelstock, Dino A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nein9urd3dqr3asangv3ldbri5